Curis
CRIS
#11127
Rank
NZ$1.14 M
Marketcap
NZ$0.59
Share price
-17.89%
Change (1 day)
-78.56%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of March 2026 : NZ$25.46 Million

According to Curis's latest financial reports the company has NZ$25.46 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$8.73 M-75.35%
2024-12-31NZ$35.45 M-60.2%
2023-12-31NZ$89.07 M-33.95%
2022-12-31NZ$0.13 B-20.51%
2021-12-31NZ$0.16 B-27.35%
2020-12-31NZ$0.23 B665.57%
2019-12-31NZ$30.5 M-15.7%
2018-12-31NZ$36.18 M-57.34%
2017-12-31NZ$84.8 M32.06%
2016-12-31NZ$64.22 M-46.52%
2015-12-31NZ$0.12 B89.13%
2014-12-31NZ$63.49 M-10.31%
2013-12-31NZ$70.79 M4.87%
2012-12-31NZ$67.51 M39.7%
2011-12-31NZ$48.32 M-8.17%
2010-12-31NZ$52.62 M51.37%
2009-12-31NZ$34.76 M-30.08%
2008-12-31NZ$49.71 M-8.14%
2007-12-31NZ$54.12 M4.02%
2006-12-31NZ$52.03 M-19.56%
2005-12-31NZ$64.68 M-6.79%
2004-12-31NZ$69.39 M27.64%
2003-12-31NZ$54.36 M-30.57%
2002-12-31NZ$78.29 M-37.6%
2001-12-31NZ$0.12 B-25.92%
2000-12-31NZ$0.16 B314.25%
1999-12-31NZ$40.89 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
NZ$22.19 B 87,060.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$17.80 B 69,802.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$95.29 M 274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.31 B 5,081.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.76 B 2,909.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$3.2 M-87.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.27 B 968.60%๐Ÿ‡บ๐Ÿ‡ธ USA